REMEDY Science, the dermatologist-developed skincare company founded by board-certified dermatologist Dr. Muneeb Shah, announced the closing of a Series A funding round led by L Catterton, with participation from existing investor Norwest and new investor Sonoma Brands Capital. Financial terms of the investment were not disclosed.
Founded in 2024, REMEDY was created to bring dermatologist-driven skincare solutions to consumers through clinically tested products designed to address common concerns such as dark spots, dryness, fine lines, dullness, keratosis pilaris, and sensitive skin. The company’s approach focuses on translating clinical expertise into accessible, high-performance formulations that prioritize efficacy and skin health.
Since launching in March 2024, the company has experienced rapid growth across multiple channels, including its direct-to-consumer website, Amazon, and TikTok Shop. REMEDY also expanded into physical retail through a nationwide launch at Target in December 2025, which the company said has delivered strong results.
The new capital will support clinical research, product development, team expansion, and inventory investments to meet growing demand across direct-to-consumer, Amazon, and Target channels. REMEDY also plans to enhance its capabilities in formulation, testing, and consumer education as it seeks to build a larger dermocosmetic platform.
L Catterton, which manages approximately $40 billion in equity capital, brings extensive experience in the beauty sector through investments in brands including Merit Beauty, TULA, ODDITY, Kopari, Elemis, and Nutrafol.
Norwest, which led REMEDY’s seed financing, participated in the Series A round, increasing its investment in the company.
Dr. Shah, whose evidence-based skincare education content has attracted more than 20 million followers globally, founded REMEDY to make dermatologist-developed skincare more accessible to consumers.
KEY QUOTES:
“For years, I saw patients who were doing everything right but still struggling to find products that delivered meaningful results without irritation or unnecessary complexity. REMEDY was created to modernize dermatologist-developed skincare. Each formula starts with a real patient need. We then innovate with the latest ingredient technologies to create clinically tested, high-efficacy formulas with a focus on visible results and safety for sensitive skin.”
Dr. Muneeb Shah, Founder And CEO, REMEDY
“We seek to partner with exceptional founders building brands that will redefine categories, and we believe REMEDY is uniquely modernizing dermatological skincare. As both a clinician and a consumer educator, Dr. Shah has built a portfolio of simple, effective, and accessibly priced products that leverage advanced ingredient technologies to address real patient needs, and that is what will define the next generation of dermocosmetics. The brand’s rapid growth reflects deep consumer demand for affordable, clinically-grounded skincare, and we are thrilled to partner with the REMEDY team on their next chapter.”
Tehmina Haider, Partner, L Catterton
“Since our initial investment, REMEDY has scaled rapidly across all channels and built consumer trust by delivering what today’s skincare consumers are looking for: efficacy, simplicity, and accessibility. REMEDY is leading a new wave of clinical skincare without the traditional prestige price. We are thrilled to double down on our partnership and continue supporting their mission to make dermatological expertise and treatments accessible to all.”
Lisa Wu, Partner, Norwest
